tiprankstipranks
Advertisement
Advertisement

PYXS Stock Latest News

Pyxis Oncology initiated with an Overweight at Wells Fargo
The FlyPyxis Oncology initiated with an Overweight at Wells Fargo
4d ago
PYXS
Pyxis Oncology Raises Capital Through Private Placement Financing
PremiumCompany Announcements
Pyxis Oncology Raises Capital Through Private Placement Financing
1M ago
8K
PYXS
Pyxis Oncology announces up to $114M private placement
PremiumThe Fly
Pyxis Oncology announces up to $114M private placement
1M ago
PYXS
Pyxis Oncology Stockholders Approve Directors and Auditor Slate
PremiumCompany Announcements
Pyxis Oncology Stockholders Approve Directors and Auditor Slate
2M ago
8K
PYXS
Pyxis Oncology Faces Urgent Capital Needs and Potential Dilution Risks Amid Market Volatility
PremiumCompany Announcements
Pyxis Oncology Faces Urgent Capital Needs and Potential Dilution Risks Amid Market Volatility
3M ago
PYXS
Pyxis Oncologyreports Q1 EPS (37c), consensus (35c)
PremiumThe FlyPyxis Oncologyreports Q1 EPS (37c), consensus (35c)
3M ago
PYXS
PYXS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PYXS Earnings this Week: How Will it Perform?
3M ago
PYXS
Wedbush bullish on Pyxis Oncology, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Pyxis Oncology, initiates with an Outperform
3M ago
PYXS
Pyxis Oncology initiated with an Outperform at Wedbush
PremiumThe Fly
Pyxis Oncology initiated with an Outperform at Wedbush
3M ago
PYXS
Pyxis Oncology price target lowered to $8 from $9 at Stifel
PremiumThe Fly
Pyxis Oncology price target lowered to $8 from $9 at Stifel
5M ago
PYXS
Pyxis Oncology Reports Q4 Results, Advances MICVO Program
PremiumCompany Announcements
Pyxis Oncology Reports Q4 Results, Advances MICVO Program
5M ago
8K
PYXS
PYXS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PYXS Earnings this Week: How Will it Perform?
5M ago
PYXS
Pyxis Oncology Announces Interim CEO Amid Leadership Transition
PremiumCompany AnnouncementsPyxis Oncology Announces Interim CEO Amid Leadership Transition
6M ago
8K
PYXS
Pyxis Oncology appoints board member Thomas Civik as Interim CEO
Premium
The Fly
Pyxis Oncology appoints board member Thomas Civik as Interim CEO
6M ago
PYXS
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
8M ago
PYXS
RGNX
Pyxis Oncology price target lowered to $5 from $8 at RBC Capital
PremiumThe Fly
Pyxis Oncology price target lowered to $5 from $8 at RBC Capital
8M ago
PYXS
Maintaining a Buy on Pyxis: Early MICVO Efficacy, Dose Optimization, and 2026 Data as the Next Major Catalyst
PremiumRatings
Maintaining a Buy on Pyxis: Early MICVO Efficacy, Dose Optimization, and 2026 Data as the Next Major Catalyst
8M ago
PYXS
Pyxis Oncology price target raised to $7 from $5 at H.C. Wainwright
PremiumThe Fly
Pyxis Oncology price target raised to $7 from $5 at H.C. Wainwright
8M ago
PYXS
Pyxis Oncology Reports Strong MICVO Data and Financing
PremiumCompany Announcements
Pyxis Oncology Reports Strong MICVO Data and Financing
8M ago
8K
PYXS
Pyxis Oncology announces preliminary Phase 1 data for micvotabart pelidotin
PremiumThe FlyPyxis Oncology announces preliminary Phase 1 data for micvotabart pelidotin
8M ago
MRK
PYXS
Pyxis to present updated data from Phase 1 monotherapy study in mid-2026
Premium
The Fly
Pyxis to present updated data from Phase 1 monotherapy study in mid-2026
8M ago
PYXS
Pyxis Oncology sees cash runway into 4Q26
Premium
The Fly
Pyxis Oncology sees cash runway into 4Q26
8M ago
PYXS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >